Details of the Drug

General Information of Drug (ID: DM7Q93M)

Drug Name

GSP 304

Indication

Disease Entry	ICD 11	Status	REF
Chronic obstructive pulmonary disease	CA22	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03118765) A Dose Ranging, Parallel Group, Active (Spiriva? Respimat?) And Placebo Controlled Study To Assess Relative Bioavailability, Pharmacodynamics And Safety Of Three Doses Of Tiotropium Bromide Inhalation Solution In Subjects With Mild To Moderate Chronic Obstructive Pulmonary Disease. U.S.National Institutes of Health.